Postdural Puncture Headache Clinical Trial
Official title:
Incidence of Post-Dural Puncture Headache Following Unintentional Dural Puncture: A Randomized Trial of Intrathecal Morphine Versus Saline
The purpose of this study is to evaluate the use of intrathecal morphine administration following an unintentional dural puncture, to decrease the incidence of post dural puncture headaches (PDPH) in obstetric patients.
Unintentional dural puncture is a known risk of neuraxial techniques, occurring in roughly 1% of all epidural catheter placements. The incidence of post dural puncture headaches(PDPH) after unintentional dural puncture (UDP) is 50-80%. A PDPH is defined as a headache that occurs following a dural puncture, worsens within 15 minutes after sitting or standing and improves within 15 minutes after lying, with at least one of the following: neck stiffness, tinnitus, hypacusia, photophobia, or nausea. The headache develops within 5 days after dural puncture and resolves either spontaneously within 1 week or within 48 hours after effective treatment of the spinal fluid leak. The rates of PDPH following unintentional dural puncture with placement of an intrathecal catheter will be compared in two groups: intrathecal morphine (treatment) versus intrathecal saline (control) administered 1-2 hours after delivery, followed by immediate catheter removal. Patients randomized to the treatment group (morphine) will receive preservative-free morphine 0.3 mL (150 mcg) intrathecally. Those randomized to the control group will receive normal saline 0.3 mL intrathecally. After administration of intrathecal morphine, all patients will have their respirations monitored every hour for a period of 12 hours and then every two hours for a period of 12 hours. On postpartum days 1-5, all patients will be visited daily while inpatient and/or contacted by phone after discharge from the hospital. PDPH can lead to significant morbidity and negatively impact patient satisfaction with postpartum recovery. Along with headache, patients may develop cranial nerve palsy during the postpartum period leading to permanent disability. In addition, new mothers are unable to bond with their babies due to headache and associated symptoms of nausea, vomiting and limited mobility secondary to pain. Therefore, an effective intervention to decrease the risk of PDPH after UDP would be useful. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03112720 -
Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache
|
Phase 3 | |
Suspended |
NCT02473276 -
2 Dose Neuraxial Morphine for Prevention of PDPH
|
Phase 4 | |
Completed |
NCT03652714 -
The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache
|
Phase 3 | |
Completed |
NCT02859233 -
Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache
|
N/A | |
Withdrawn |
NCT02181205 -
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
|
N/A | |
Completed |
NCT06394024 -
Examination of Postdural Puncture Headache Frequency, Predisposing Factors and Treatment
|
||
Withdrawn |
NCT03966547 -
Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714
|
N/A | |
Completed |
NCT06380764 -
Greater Occipital Nerve Block Value in Management of Postdural Puncture Headache
|
N/A | |
Terminated |
NCT02365909 -
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
|
Early Phase 1 | |
Completed |
NCT04910477 -
Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache
|
Phase 3 | |
Completed |
NCT05969119 -
Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache
|
Phase 4 | |
Completed |
NCT02150304 -
Aminophylline Prophylaxis For Postdural Puncture Headache
|
N/A | |
Not yet recruiting |
NCT04709029 -
Effect of Intravenous Versus Intrathecal Dexamethazone on Postdural Puncture Headache
|
N/A | |
Withdrawn |
NCT02517931 -
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
|
N/A | |
Recruiting |
NCT06271486 -
Pregabalin in Treatment of Postdural Puncture Headache
|
Phase 3 | |
Completed |
NCT00465166 -
Lumbar Spine Ultrasound of Patients With Previous Accidental Dural Puncture During Labour Epidural
|
N/A | |
Not yet recruiting |
NCT05212194 -
The Relationship Between Post Dural Puncture Headache and Joint Laxity
|
N/A | |
Completed |
NCT05777694 -
Postdural Punction Headache After Ceserian Section
|
N/A | |
Withdrawn |
NCT04515901 -
Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches
|
N/A | |
Completed |
NCT04892290 -
Sphenopalatine Ganglion Block for Postdural Puncture Headache
|